🇺🇸 ABBV — AbbVie Inc.

Healthcare Compra
← Volver

Precio actual

256,46 USD

Máx. histórico

267,47

37 días

Caída desde máximo

-4,12%

Rango 52 semanas

190,75 – 267,47

Variación hoy

-1,44%

Cierre anterior

260,21

Rango de hoy

255,61 – 258,91

Volumen hoy

4.701.126

Información
Nombre completo
AbbVie Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
57.000
PER ⓘ
72,45 (puede no estar actualizado)
Dividend yield
2,70% (puede no estar actualizado)
Precio objetivo analistas
276,59 USD (puede no estar actualizado)
Primera cotización
02/01/2013
Precio actualizado
hace 2 días
Sobre la empresa

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Dividendos repartidos Total últimos 12 meses: 6,8300 USD · Yield: 2,66%
Fecha de pago Importe por participación
14/01/2019 1,0700 USD
12/10/2018 0,9600 USD
12/07/2018 0,9600 USD
12/04/2018 0,9600 USD
11/01/2018 0,7100 USD
12/10/2017 0,6400 USD
12/07/2017 0,6400 USD
11/04/2017 0,6400 USD
11/01/2017 0,6400 USD
12/10/2016 0,5700 USD
13/07/2016 0,5700 USD
13/04/2016 0,5700 USD
13/01/2016 0,5700 USD
13/10/2015 0,5100 USD
13/07/2015 0,5100 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/05/2019 81,09 81,10 79,87 80,06 -1,34% 1,52% 3.872.700
23/05/2019 80,39 81,63 80,32 81,15 -0,54% 1,63% 3.299.100
22/05/2019 80,51 81,75 79,88 81,59 +0,88% 2,32% 4.219.500
21/05/2019 80,33 81,50 80,32 80,88 +1,33% 1,47% 4.841.900
20/05/2019 79,02 80,39 78,91 79,82 +0,45% 1,87% 4.395.500
17/05/2019 78,53 80,08 78,02 79,46 -0,05% 2,62% 4.756.400
16/05/2019 78,98 80,75 78,71 79,50 +0,91% 2,58% 5.404.700
15/05/2019 78,51 79,15 77,48 78,78 +0,43% 2,13% 4.795.700
14/05/2019 77,16 79,36 77,00 78,44 +2,04% 3,06% 6.365.200
13/05/2019 76,30 77,30 76,17 76,87 -0,75% 1,48% 3.858.400
10/05/2019 77,45 77,73 75,62 77,45 -0,59% 2,72% 4.731.800
09/05/2019 77,51 78,13 76,73 77,91 -0,10% 1,81% 3.792.200
08/05/2019 77,95 78,89 77,32 77,99 +0,05% 2,01% 3.820.700
07/05/2019 78,60 78,99 77,17 77,95 -1,65% 2,32% 4.275.300
06/05/2019 77,75 79,52 77,34 79,26 +0,70% 2,80% 5.413.200
03/05/2019 78,72 78,80 78,25 78,71 +0,31% 0,70% 4.527.300
02/05/2019 78,73 78,78 77,60 78,47 -0,53% 1,50% 5.206.300
01/05/2019 79,60 79,68 78,61 78,89 -0,63% 1,34% 5.231.700
30/04/2019 80,68 80,69 78,68 79,39 -1,13% 2,49% 9.367.400
29/04/2019 80,46 80,98 79,91 80,30 +0,75% 1,33% 6.444.500
26/04/2019 79,67 80,65 79,40 79,70 +0,45% 1,57% 5.790.000
25/04/2019 80,05 80,47 76,91 79,34 +0,85% 4,45% 10.442.900
24/04/2019 79,23 79,59 78,44 78,67 +0,01% 1,45% 7.056.400
23/04/2019 78,15 79,66 77,75 78,66 +0,65% 2,44% 9.920.600
22/04/2019 77,60 79,10 77,50 78,15 +0,75% 2,06% 5.358.600
18/04/2019 78,06 78,21 76,81 77,57 -0,53% 1,79% 7.784.900
17/04/2019 80,10 80,20 77,55 77,98 -2,78% 3,31% 6.817.100
16/04/2019 81,11 81,30 80,02 80,21 -1,01% 1,58% 3.624.700
15/04/2019 80,96 81,51 80,37 81,03 +0,31% 1,41% 3.495.500
12/04/2019 80,67 81,81 79,84 80,78 -1,21% 2,44% 5.011.500